Cryofocus Medtech (Shanghai) Co (HKSE:06922) PB Ratio : 10.69 (As of May. 11, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-11), Cryofocus Medtech (Shanghai) Co's share price is HK$7.90. Cryofocus Medtech (Shanghai) Co's Book Value per Share for the quarter that ended in Jun. 2023 was HK$0.74. Hence, Cryofocus Medtech (Shanghai) Co's PB Ratio of today is 10.69.

Warning Sign:

Cryofocus Medtech (Shanghai) Co Ltd stock PB Ratio (=17.83) is close to 1-year high of 18.820000

The historical rank and industry rank for Cryofocus Medtech (Shanghai) Co's PB Ratio or its related term are showing as below:

HKSE:06922' s PB Ratio Range Over the Past 10 Years
Min: 8.51 Med: 15.22 Max: 20.21
Current: 10.68

During the past 4 years, Cryofocus Medtech (Shanghai) Co's highest PB Ratio was 20.21. The lowest was 8.51. And the median was 15.22.

HKSE:06922's PB Ratio is ranked worse than
93.43% of 792 companies
in the Medical Devices & Instruments industry
Industry Median: 2.235 vs HKSE:06922: 10.68

Back to Basics: PB Ratio

Cryofocus Medtech (Shanghai) Co PB Ratio Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co PB Ratio Chart

Cryofocus Medtech (Shanghai) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

PB Ratio

15.81

25.47

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
PB Ratio	Get a 7-Day Free Trial			-	-	15.81	18.91	25.47

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's PB Ratio

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryofocus Medtech (Shanghai) Co's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's PB Ratio falls into.

Cryofocus Medtech (Shanghai) Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Cryofocus Medtech (Shanghai) Co's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Jun. 2023)
	=	7.90	/	0.739
	=	10.69

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Cryofocus Medtech (Shanghai) Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Building 15, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 200120

Website

https://www.cryofocus.com

Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Headlines

No Headlines